BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/09/2023

FDA Withdraws Oxandrin Tablets Due to Safety and Effectiveness Concerns

The US Food and Drug Administration has determined that Oxandrin tablets in 2.5mg and 10mg doses were removed from sale due to concerns over safety and effectiveness, and will no longer accept new applications for these formulations.

Source: Federal Register — Food and Drug AdministrationOpen original release →